Regenerative Medicine Clinical Trials

As a patient at Cedars-Sinai, you will have access to the latest clinical trials and research for regenerative medicine. Backed by a respected team of specialists and researchers, our clinical trials aim to further the advancement of diagnosing and treating your condition.

Questions? See the Clinical Trials FAQs.

Key Inclusion Criteria:

  • Patients with cardiovascular disease who are identified by their treating physicians and referred to the study

Summary:

This study will examine heart tissue samples from individuals whose treating physician has recommended cardiac surgery for coronary bypass, or to repair or replace a heart valve for clinically indicated purposes. The purpose of the study is to learn more about a newly discovered type of heart stem cell. Researchers will examine these cells to determine whether they have the ability to grow and improve the heart function of damaged hearts. The study also aims to learn more about newly discovered spherical clusters of these heart stem cells known as cardiospheres.

DCM Precision Medicine Study

Condition: 

Idiopathic Dilated Cardiomyopathy

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) (MAVERICK-HCM)

Condition: 

Non-obstructive Hypertrophic Cardiomyopathy

Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFPEF Patients Treated With Allogeneic CDCs (Regress-HFpEF)

Condition: 

Congestive Heart Failure, Heart Failure (Diastolic)